Rolf Bulk, equity research analyst at New Street Research says there is no clear catalyst for the discount between Softbank's ...

SoftBank’s AI investments face increasing risks, especially in OpenAI and Stargate. Find out why SFTBF stock could be ...

DeepSeek may spark a “near-term market correction” for SoftBank and other AI stocks, said chief executive officer Yun Jung-in ...

Japan's SoftBank Group booked a surprise $2.4 billion quarterly loss on Wednesday, hit by a decline in the value of ...

SoftBank is steering a $500 billion fundraising for the Stargate Project to develop AI infrastructure in the U.S., a plan ...

Three weeks after unveiling a massive data-center project with OpenAI that could run to half a trillion dollars, global tech ...

An initial public offering from a key global supplier of semiconductor materials is seeking to raise about ¥460 billion ($3 ...

SoftBank Group Corp. tumbled to a loss in the December quarter, weighed down by a drop in the value of the Vision Fund’s ...

SoftBank disclosed a 20.45M share position in PacBio (PACB) and 14.67M share position in Recursion Pharmaceuticals (RXRX) in a regulatory ...

While market sentiments among SoftBank investors remain pessimistic due to the emergence of more low-cost alternatives from China, there is still hope.

The deal would exceed last year’s blockbuster share debut of subway operator Tokyo Metro, and be the largest since SoftBank’s ...

SoftBank’s founder Masayoshi Son is known for chasing the next big thing. Some of his big bets on tech companies, such as ...